Adolescence is a critical developmental period for tobacco initiation and progression to regular use and dependence. Comprehensive tobacco control policies that reduce the reinforcing effects of cigarettes in adolescents may decrease the number of cigarette experimenters who go on to become lifelong smokers. With the passage of the Family Smoking Prevention and Tobacco Control Act in 2009, the Food and Drug Administration (FDA) was granted the authority to establish standards for tobacco products as appropriate for the protection of public health, including the authority to mandate a reduction in the nicotine content of all cigarettes to minimally addictive levels. Numerous studies have found that adult smokers who are switched to very low nicotine content (VLNC) cigarettes experience reductions in smoking rates, nicotine intake, nicotine dependence and abstinence-induced craving relative to those who use normal nicotine content (NNC) cigarettes. However, to date, studies of VLNC cigarettes have excluded adolescent smokers, and are critically needed to inform potential product standards. Furthermore, as use of electronic cigarettes (e-cigarettes) has increased dramatically in adolescents, effects of VLNC cigarettes on smoking in youth must be examined in the context of e-cigarette availability. Project 3 is a 2 x 2 x 2 mixed-factors laboratory study in which a smoking choice procedure will be used to determine how the nicotine content of cigarettes and key characteristics of e- cigarettes (nicotine concentration and flavors) influence use of these products and their subjective effects in adolescents. In this single-site study, adolescents aged 15-19 (N=120), who are daily cigarette smokers and have used e-cigarettes on at least 5 occasions, will first complete a baseline session in which eligibility criteria are confirmed, background questionnaires are completed and participants gain experience with the e-cigarette device to be used in later sessions. Next, participants will complete 5 lab sessions in which NNC (15.8 mg/g) or VLNC (0.4 mg/g) cigarettes are available and e-cigarettes varying in nicotine concentration (2 mg/mL or 18 mg/mL) and flavor (tobacco or non-tobacco) are concurrently available. After sampling and rating the subjective effects of each product, participants will make a series of 10 choices between 2 puffs of either product or abstinence. An additional lab session during which e-cigarettes are not available will allow a direct comparison of the effects of NNC and VLNC cigarettes on smoking when no alternative product is available. We hypothesize that reducing the nicotine content of cigarettes will reduce cigarette choices and increase both e-cigarette choices and choices to abstain from either product. We further hypothesize that e-cigarettes with higher nicotine concentration and non-tobacco flavor will be most effective at reducing cigarette choices. We will also test the impact of these factors on the subjective effects of each product and explore whether the behavioral and subjective effects of each product vary as a function of age and gender. This project will provide the FDA with critically important information on how the nicotine content of combusted tobacco affects the reinforcing and subjective effects of cigarettes in adolescents, and how those effects are altered when e- cigarettes with different characteristics are available as alternatives.

Public Health Relevance

Studies that investigate the use and effects of very low nicotine cigarettes in adolescents, particularly in the context of electronic cigarette availability, are critically needed to inform potential decisions by the Food and Drug Administration (FDA) related to tobacco product standards. This laboratory study will investigate the subjective and reinforcing effects of very low nicotine contents and electronic cigarettes varying in nicotine content and flavor in adolescent daily smokers who have used e-cigarettes on at least 5 occasions. This project will provide the FDA with critically important information on how the nicotine content of combusted tobacco affects the reinforcing and subjective effects of cigarettes in adolescents, and how those effects are altered when e-cigarettes with different characteristics are available as alternatives.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54DA031659-06
Application #
9149860
Study Section
Special Emphasis Panel (ZDA1-JXR-G (01)S)
Project Start
Project End
2017-09-30
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
6
Fiscal Year
2017
Total Cost
$448,423
Indirect Cost
$13,750
Name
University of Pittsburgh
Department
Type
Domestic Higher Education
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Villanti, Andrea C; Gaalema, Diann E; Tidey, Jennifer W et al. (2018) Co-occurring vulnerabilities and menthol use in U.S. young adult cigarette smokers: Findings from Wave 1 of the PATH Study, 2013-2014. Prev Med 117:43-51
Pericot-Valverde, Irene; Elliott, Rebecca J; Miller, Mollie E et al. (2018) Posttraumatic stress disorder and tobacco use: A systematic review and meta-analysis. Addict Behav 84:238-247
Denlinger-Apte, Rachel L; Tidey, Jennifer W; Koopmeiners, Joseph S et al. (2018) Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes. Tob Control :
Parker, Maria A; Streck, Joanna M; Bergeria, Cecilia L et al. (2018) Reduced Nicotine Content Cigarettes and Cannabis Use in Vulnerable Populations. Tob Regul Sci 4:84-91
Kazi, Abid; Fazzi, Alyse; Krebs, Nicolle M et al. (2018) Cigarette Management System: An operating procedures guide to obtaining and managing investigational tobacco products for regulatory science research. Contemp Clin Trials Commun 11:69-74
Hatsukami, Dorothy K; Luo, Xianghua; Jensen, Joni A et al. (2018) Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. JAMA 320:880-891
Boatman, Jeffrey A; Vock, David M; Koopmeiners, Joseph S et al. (2018) Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. Biostatistics 19:103-118
Hatsukami, Dorothy K; Donny, Eric C (2018) The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller. Nicotine Tob Res :
Smith, Tracy T; Hatsukami, Dorothy K; Benowitz, Neal L et al. (2018) Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health. Prev Med 117:8-14
Dermody, Sarah S; McClernon, F Joseph; Benowitz, Neal et al. (2018) Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence. Exp Clin Psychopharmacol 26:223-232

Showing the most recent 10 out of 63 publications